Analysis of sociodemographic,pharmacotthreapy-relatedand illness-related factors affecting neurocognitive disturbance in patients with schizophrenia

Analysis of sociodemographic,pharmacotthreapy-relatedand illness-related factors affecting neurocognitive disturbance in patients with schizophrenia - Analysis of factors affecting cognitive disturbance in patients with schizophrenia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008644

Enrollment

100

Registered

2012-08-08

Start date

2005-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All the patients had been diagnosed as schizophrenia, had been taking a stable dose of antipsychotics for at least 4 weeks.

Exclusion criteria

Exclusion criteria: None of the patients had a history of seizure disorder, renal insuffficiency, dementia, substance misuse, including alcohol problems.

Design outcomes

Primary

Measure	Time frame
The degree of contributions of sociodemographic, illness-related, and pharmacotherapy-related factors to the scores of neurocognitive tests	—

Countries

Japan

Contacts

Public ContactNaoki Hashimoto

Graduate School of Medicine, Hokkaido University Department of Psychiatry

011-706-5160

Outcome results